Company
Headquarters: New Taipei City, Taiwan
CEO: Gene Chen
TW$2.39 Billion
TWD as of July 1, 2025
US$81.5 Million
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $162.07 B |
| Danaher | $144.92 B |
| Siemens Healthineers AG | $64.17 B |
| Lonza Group Ltd | $49.67 B |
| IDEXX Laboratories, Inc. | $43.99 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
DIVA Laboratories, Ltd. manufactures and sells display solutions worldwide. It provides endo/surgical displays, which provide static and dynamic images for hybrid and integrated ORs, and control room applications; color and mono displays for radiology and medical imaging; touch displays; and displays to ODM and OEM customers. The company is headquartered in New Taipei City, Taiwan.
DIVA Laboratories Ltd has the following listings and related stock indices.
Stock: TWSE: 4153 wb_incandescent